Common questions about Quensyl (FAQ)
Q: Is Quensyl considered a steroid medicine?
According to official classification, Quensyl (hydroxychloroquine) is not a steroid. It is classified as an antimalarial and a Disease-Modifying Anti-Rheumatic Drug (DMARD), which belongs to the aminoquinolines group of medicines. Steroids are a different class of medication with a distinct mechanism of action.
Q: How often are eye checks recommended when taking Quensyl?
Regular eye monitoring is recommended because of the risk of ocular toxicity, which can affect vision. Official guidelines from professional bodies and regulatory documents generally suggest an annual monitoring assessment after five years of therapy for individuals considered low-risk. The timing of monitoring depends on individual risk factors, such as kidney status or co-administered medications, which requires the guidance of an eye care specialist and prescriber.
Q: Can Quensyl cause changes in mood, like anxiety or depression?
Yes, official product information lists that psychiatric disorders have been reported as potential adverse reactions. These reactions can include changes in mood such as anxiety, nervousness, irritability, psychosis, suicidal behavior, and nightmares. If an individual experiences changes in mood or behavior, they are advised to seek guidance from their healthcare provider.
Q: Does Quensyl have any effect on hair loss or hair color?
Official regulatory documents indicate that reactions affecting the skin and hair are potential adverse effects. These include alopecia (hair loss) and changes in hair color. Pigmentation changes in the skin and mucous membranes are also listed as possible reactions.
Q: Should I limit or avoid alcohol completely while on Quensyl?
While regulatory documents do not list a direct interaction between Quensyl and alcohol, the official cautions note that alcohol intake may intensify certain central nervous system and gastrointestinal side effects already associated with the medication, such as dizziness, headache, and nausea.
Q: Does Quensyl make a person more sensitive to the sun?
Yes, regulatory documents list photosensitivity as a potential adverse reaction. Due to this risk, official guidance recommends protective measures against sun exposure.
Q: Is it possible to experience weight changes while taking Quensyl?
Official product information lists changes in metabolism and nutrition as potential adverse reactions. Specifically, decreased appetite and weight decreased are listed side effects. Individuals using the medication may wish to monitor for such changes.
Q: Can Quensyl interact with common antibiotics?
Official product information notes caution regarding co-administration with certain types of antibiotics, as this may increase the risk of adverse cardiac effects. The 'Interactions' section of the official label provides a full list of constrained co-administered medicines.
Q: What is the difference between Quensyl and Plaquenil?
Quensyl and Plaquenil are both simply brand names for the exact same active pharmaceutical ingredient, which is hydroxychloroquine sulfate. There is no clinical difference between the active medicine in a Quensyl tablet and a Plaquenil tablet.
Q: How long does Quensyl stay in the body after a person stops taking it?
The drug is eliminated very slowly from the body due to its extensive uptake into tissues. Official pharmacokinetics data indicates that the terminal half-life in plasma after chronic use is estimated to be approximately 40 to 50 days. This means the medicine stays in the body for an extended period after the last dose.
Q: Is it necessary to avoid certain foods when taking Quensyl?
While most foods do not pose a problem, official warnings note that consuming grapefruit or grapefruit juice may significantly increase the concentration of the drug in the blood. This effect may result in higher drug levels in the bloodstream, which is generally avoided.
Q: Does Quensyl have a risk of causing headaches?
Yes, headache is a listed potential adverse reaction in the nervous system disorders section of official product information. This is a common side effect reported with many types of medication.
Q: Is it normal to feel tired or weak when first starting Quensyl?
According to the official product information, fatigue (low energy) and generalized weakness are listed as potential adverse reactions. These effects are possible when starting the medication.
Q: Can Quensyl cause ringing in the ears?
Yes, the product labeling lists adverse reactions affecting the ear and labyrinth. These include tinnitus (ringing in the ears) and vertigo (a sensation of spinning or dizziness).
Q: Does Quensyl require special eye monitoring?
Due to the potential for ocular toxicity, which can lead to potentially irreversible damage to the retina, it is stated in regulatory guidance that individuals must undergo regular ophthalmic examinations. This monitoring is a standard procedure intended to help manage the risk of ocular changes.
Q: What are the signs of a possible serious skin reaction to Quensyl?
The medication can rarely cause severe cutaneous (skin) adverse reactions, such as Stevens-Johnson syndrome (SJS). Signs that may indicate a serious reaction include blistering, peeling or loosening of the skin, and red skin lesions, sometimes accompanied by a fever. Individuals who notice any of these signs are advised to contact a healthcare professional immediately.
Q: Why might a doctor prescribe blood tests while a person is taking Quensyl?
Blood tests are often required because the drug can rarely affect blood cell counts and the liver. Monitoring is necessary to check for serious, though uncommon, effects like agranulocytosis (a severe decrease in a type of white blood cell) and acute hepatic failure (severe liver problems).
Q: Is Quensyl considered an immunosuppressant drug?
Quensyl is formally classified as an antirheumatic and an immunomodulator. While it does affect the immune system to help treat conditions like lupus and rheumatoid arthritis, the clinical effect on the immune response is often considered milder than traditional, potent immunosuppressive drugs.
Q: Can Quensyl affect the results of a blood test?
Yes, monitoring is required for possible changes in blood cell counts, such as leukopenia (low white blood cell count). Additionally, blood tests may be used to track the risk of hypoglycemia (low blood sugar) and monitor lipid profiles, as the medication has been associated with effects on these metabolic factors.
Q: Does Quensyl make a person more susceptible to infections?
The drug is monitored because it may rarely cause adverse effects on the blood system, such as a decrease in certain blood cell counts (e.g., leukopenia or agranulocytosis). Because white blood cells fight infection, a decrease in these cells could potentially increase susceptibility to infection.
